What is the market cap of Richter Gedeon?
Gedeon Richter Plc commands a multi-billion-dollar market capitalization on the Budapest Stock Exchange, highlighting its prominent position as a leading multinational pharmaceutical and biotechnology enterprise headquartered in Hungary. Its equity worth is propelled by specialized research and development portfolios focused on women's health, central nervous system disorders, and original biosimilar drug manufacturing.
Related FAQs
Gedeon Richter operates primarily as an original research-based pharmaceutical company that focuses on developing and manufacturing proprietary prescription medicines, particularly in women's health, central nervous system disorders, and cardiovascul...
Gedeon Richter Plc., a major multinational pharmaceutical and biotechnology company headquartered in Central Europe, has its primary seat and corporate headquarters located at Gyömrői út 19-21, in Budapest, Hungary.
Gedeon Richter Plc is a major European pharmaceutical company based in Hungary that is used for a wide range of medical treatments, particularly in the fields of women's healthcare, psychiatry, and neurology.
Gedeon Richter was a pioneering Hungarian pharmacist, industrialist, and founder of the multinational pharmaceutical company that bears his name.
Gedeon Richter Plc. is a fully public corporate entity whose shares are officially listed and traded on the Budapest Stock Exchange, where it maintains significant representation as a blue-chip enterprise.
Retiring at age 65 with a nest egg of $2 million is generally considered more than sufficient for the vast majority of individuals to maintain a comfortable, secure lifestyle throughout their retirement years.